Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Health Canada authorized Moderna's updated COVID-19 vaccine that protects against currently circulating variants of the virus ...

The U.S. Food and Drug Administration approved the vaccines by Pfizer and Moderna for people 12 years ... provided by Pfizer in August 2024 shows a vial of the company's updated COVID vaccine ...

Health Canada authorized Moderna's updated COVID-19 vaccine on Tuesday to roll out in fall immunization campaigns. The federal vaccine portal lists approval of Moderna's product. Provinces and ...

The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna the OK on ... An illustration picture shows vials with Covid-19 Vaccine ...

The Food and Drug Administration (FDA) announced Thursday the approval of both Pfizer’s and Moderna’s updated COVID-19 vaccines for the 2024-2025 respiratory viral season. The updated vaccines ...

Moderna (MRNA) plans to launch a skin cancer vaccine developed with Merck (MRK) in 2025, but faces stock pressure after ...

Moderna, Inc.'s combination flu and COVID-19 vaccine, mRNA-1083, showed strong Phase 3 results in adults over 50. Pfizer/BioNTech's combination vaccine faced setbacks, giving Moderna a potential ...

Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...

ACCESSWIRE • 9 days ago EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending and pushed back its time frame for breaking even Shares of Moderna ...

An updated COVID-19 vaccine is coming to Canada just in time for fall. On Tuesday, Health Canada announced it had approved Moderna’s latest COVID vaccine that’s been reformulated to target prevalent ...